Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
31.34
Dollar change
+0.04
Percentage change
0.13
%
IndexRUT P/E61.83 EPS (ttm)0.51 Insider Own15.91% Shs Outstand78.17M Perf Week4.43%
Market Cap2.47B Forward P/E9.43 EPS next Y3.32 Insider Trans0.65% Shs Float66.27M Perf Month8.07%
Income40.23M PEG9.81 EPS next Q0.62 Inst Own82.81% Short Float4.73% Perf Quarter-0.92%
Sales1.53B P/S1.61 EPS this Y-2.05% Inst Trans1.28% Short Ratio1.92 Perf Half Y-26.07%
Book/sh20.29 P/B1.54 EPS next Y9.42% ROA1.03% Short Interest3.13M Perf Year-30.28%
Cash/sh8.41 P/C3.72 EPS next 5Y6.30% ROE2.46% 52W Range22.36 - 46.75 Perf YTD-28.04%
Dividend Est.- P/FCF40.53 EPS past 5Y3.10% ROI1.12% 52W High-32.96% Beta1.11
Dividend TTM- Quick Ratio3.35 Sales past 5Y1.17% Gross Margin57.02% 52W Low40.16% ATR (14)1.09
Dividend Ex-Date- Current Ratio4.68 EPS Y/Y TTM-75.47% Oper. Margin8.77% RSI (14)62.00 Volatility4.61% 3.50%
Employees5329 Debt/Eq1.28 Sales Y/Y TTM-2.07% Profit Margin2.63% Recom3.00 Target Price35.40
Option/ShortYes / Yes LT Debt/Eq1.26 EPS Q/Q-114.34% Payout0.00% Rel Volume0.53 Prev Close31.30
Sales Surprise1.41% EPS Surprise-0.36% Sales Q/Q-3.14% EarningsJul 29 BMO Avg Volume1.63M Price31.34
SMA205.99% SMA508.20% SMA200-12.64% Trades Volume864,435 Change0.13%
Date Action Analyst Rating Change Price Target Change
May-07-24Downgrade Wells Fargo Overweight → Equal Weight $45 → $25
May-07-24Downgrade Oppenheimer Outperform → Perform
Apr-03-24Upgrade Citigroup Sell → Neutral $38
Dec-05-23Upgrade Wells Fargo Equal Weight → Overweight $40 → $49
Nov-14-23Initiated CL King Buy $50
Aug-24-23Downgrade Morgan Stanley Equal-Weight → Underweight $44
Jul-12-23Upgrade Jefferies Hold → Buy $58 → $53
Jun-08-23Downgrade Argus Buy → Hold
May-24-23Downgrade JP Morgan Neutral → Underweight $56 → $43
May-23-23Downgrade Citigroup Neutral → Sell $59 → $39
Jul-19-24 08:34AM
Jul-17-24 08:00AM
Jul-16-24 09:14AM
Jul-15-24 08:00AM
08:00AM
06:09PM Loading…
Jun-07-24 06:09PM
Jun-05-24 11:30AM
May-30-24 05:39PM
May-28-24 01:34PM
04:22AM
May-17-24 07:54AM
May-13-24 04:30PM
12:07PM
May-08-24 12:15AM
May-07-24 11:33AM
11:10AM Loading…
11:10AM
08:02AM
07:27AM
07:19AM
03:02AM
01:45AM
May-06-24 01:23PM
12:35PM
12:35PM
10:53AM
09:30AM
06:29AM
06:10AM
06:00AM
Apr-30-24 04:20PM
05:24PM Loading…
Apr-18-24 05:24PM
Apr-17-24 10:01AM
Apr-09-24 08:41AM
Apr-01-24 04:15PM
Mar-29-24 11:30AM
Mar-13-24 08:17AM
Mar-12-24 12:04PM
Mar-11-24 08:30AM
Feb-29-24 11:46AM
10:43AM
05:52AM
Feb-28-24 10:46PM
09:30AM
07:15AM
06:32AM
06:28AM
06:25AM
06:00AM
06:00AM
Feb-27-24 05:03AM
Feb-26-24 09:15AM
Feb-21-24 10:00AM
Feb-07-24 09:15AM
Jan-20-24 03:19PM
Jan-10-24 07:13AM
Jan-05-24 04:30PM
Dec-14-23 11:14AM
Dec-13-23 06:15AM
06:04AM
Dec-12-23 12:00PM
Nov-24-23 11:31AM
Nov-08-23 08:00AM
Oct-26-23 10:52AM
08:20AM
Oct-25-23 09:30AM
08:06AM
07:15AM
06:13AM
06:00AM
Oct-13-23 11:40AM
Oct-11-23 06:53PM
Oct-10-23 05:38PM
Oct-05-23 08:25AM
Oct-04-23 08:00AM
Sep-28-23 11:49AM
Sep-27-23 05:56PM
Sep-07-23 07:37PM
Sep-01-23 05:04PM
Aug-31-23 08:37AM
Aug-25-23 11:31AM
10:26AM
Aug-13-23 05:49PM
Aug-10-23 08:51AM
Aug-07-23 02:28PM
Jul-28-23 11:12AM
Jul-26-23 08:00PM
07:45PM
06:39PM
06:30PM
11:04AM
Jul-24-23 01:51PM
10:00AM
Jul-20-23 10:02AM
Jul-13-23 01:07AM
Jul-11-23 10:50AM
Jul-03-23 04:45PM
Jun-29-23 08:39AM
Jun-28-23 04:15PM
Jun-21-23 04:15PM
Jun-12-23 04:08PM
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ESSIG STUARTExec. Chairman of the BoardMay 23 '24Buy28.4952,6411,499,979487,922May 24 04:08 PM
HILL BARBARA BDirectorMay 21 '24Buy27.4036,350995,81636,350May 22 04:09 PM
De Witte JanPresident & CEOMar 11 '24Option Exercise0.00205018,555Mar 13 04:30 PM
De Witte JanPresident & CEOMar 10 '24Option Exercise0.00346018,696Mar 12 05:12 PM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 10 '24Option Exercise0.001,17901,179Mar 12 05:10 PM
DAVIS ROBERT T. JR.EVP & President, TTMar 06 '24Option Exercise32.598,736284,66358,241Mar 08 04:22 PM
DAVIS ROBERT T. JR.EVP & President, TTMar 06 '24Sale36.598,348305,49249,893Mar 08 04:22 PM
De Witte JanPresident & CEOJan 18 '24Option Exercise0.00597018,947Jan 19 04:43 PM
De Witte JanPresident & CEONov 01 '23Option Exercise0.009,814022,612Nov 03 04:27 PM
Mosebrook JeffreySVP, Fin & PAOAug 09 '23Sale44.461,17752,32923,458Aug 10 04:11 PM